Suppr超能文献

系统性硬化症患者代谢和内皮因子血清水平的改变。

Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.

机构信息

Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008, Warsaw, Poland.

出版信息

Arch Dermatol Res. 2020 Aug;312(6):453-458. doi: 10.1007/s00403-019-01993-y. Epub 2019 Oct 30.

Abstract

Systemic sclerosis (SSc) is a chronic connective tissue disease characterized by progressive fibrosis, vascular impairment and immune abnormalities. In recent years, adipokines (mediators synthetized by adipose tissue) have been indicated as a possible missing link in the pathogenesis of SSc. The aim of this study was to investigate the serum concentration of metabolic adipose tissue factors: adiponectin, resistin, leptin and endothelial proteins: endothelin-1, fractalkine and galectin-3 in patients with systemic sclerosis. The study included 100 patients with confirmed SSc diagnosis and 20 healthy individuals. The concentration of respective proteins was determined by enzyme-linked immunosorbent assay. The following markers showed statistically significant increased mean concentrations in patients with SSc in comparison to healthy control: resistin (13.41 vs 8.54 ng/mL; P = 0.0012), endothelin-1 (1.99 vs 1.31 pg/mL; P = 0.0072) and fractalkine (2.93 vs 1.68 ng/mL; P = 0.0007). Elevated serum levels of galectin-3 (4.54 vs 3.26 ng/mL; P = 0.0672) and leptin (19,542 vs 14,210 pg/mL; P = 0.1817) were observed. Decreased concentration of adiponectin was found in patients with SSc (5150 vs 8847 pg/mL; P = 0.0001). Fractalkine and galectin-3 levels were significantly higher in diffuse cutaneous SSc than limited cutaneous SSc subset (3.93 ng/mL vs 2.58 ng/mL, P = 0.0018; 6.86 ng/mL vs 3.78 ng/mL, P = 0.0008, respectively) and correlated positively with modified Rodnan Skin Score in total SSc patients (r = 0.376, P = 0.0009; r = 0.236, P = 0.018, respectively). In conclusion, an increased serum level of resistin associated with increased endothelin-1 and fractalkine level and decreased adiponectin level may indicate a significant role of the adipose tissue in the development and progression of vascular abnormalities in patients with systemic sclerosis. Fractalkine and galectin-3 may participate in promoting and exacerbating the fibrotic process in SSc.

摘要

系统性硬化症(SSc)是一种慢性结缔组织疾病,其特征为进行性纤维化、血管损伤和免疫异常。近年来,脂肪细胞因子(脂肪组织合成的介质)被认为是 SSc 发病机制中的一个潜在缺失环节。本研究旨在探讨代谢性脂肪组织因子:脂联素、抵抗素、瘦素和内皮蛋白:内皮素-1、 fractalkine 和半乳糖凝集素-3 在系统性硬化症患者中的血清浓度。该研究纳入了 100 例确诊的 SSc 患者和 20 名健康个体。通过酶联免疫吸附试验测定各蛋白的浓度。与健康对照组相比,SSc 患者的以下标志物显示出统计学上显著升高的平均浓度:抵抗素(13.41 与 8.54ng/mL;P=0.0012)、内皮素-1(1.99 与 1.31pg/mL;P=0.0072)和 fractalkine(2.93 与 1.68ng/mL;P=0.0007)。还观察到血清半乳糖凝集素-3(4.54 与 3.26ng/mL;P=0.0672)和瘦素(19542 与 14210pg/mL;P=0.1817)水平升高。SSc 患者的脂联素浓度降低(5150 与 8847pg/mL;P=0.0001)。弥漫性皮肤 SSc 患者的 fractalkine 和半乳糖凝集素-3 水平明显高于局限性皮肤 SSc 患者(3.93ng/mL 与 2.58ng/mL,P=0.0018;6.86ng/mL 与 3.78ng/mL,P=0.0008),并且与总 SSc 患者的改良 Rodnan 皮肤评分呈正相关(r=0.376,P=0.0009;r=0.236,P=0.018)。总之,抵抗素水平升高与内皮素-1 和 fractalkine 水平升高以及脂联素水平降低相关,这可能表明脂肪组织在系统性硬化症患者血管异常的发生和发展中具有重要作用。Fractalkine 和半乳糖凝集素-3 可能参与促进和加重 SSc 的纤维化过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/561b/7306018/20fa6f6d3d81/403_2019_1993_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验